Biognosys in-licenses a new technology published in Science
The application range of the LiP technology is very broad since protein conformational changes can result from a variety of events such as protein-protein interactions, compound-protein interactions, posttranslational modifications, etc.
Biognosys is currently developing applications of the LiP technology such as the identification of small molecule binding sites (e.g. for drug target deconvolution) and proteome-wide discovery of induced structural changes. Biognosys plans to commercialize the technology as a contract research services later this year.